Literature DB >> 3382497

Estimating the regression-to-mean effect associated with road accident black spot treatment: towards a more realistic approach.

C C Wright1, C R Abbess, D F Jarrett.   

Abstract

Until recently, the evaluation of engineering remedial measures at road accident Black Spots was seen as a routine exercise. However, the regression-to mean effect has been found to distort comparisons between before-and-after accident data to a significant extent, and for this and other reasons the problem can no longer be considered as straightforward. Various methods for applying corrections for regression-to-mean have been proposed. They rely on various assumptions about the data which have not been properly investigated or justified. These assumptions relate to the nature of the distribution of mean accident rates between sites, the nature of the population from which the sites are drawn, and the validity of using total accident frequencies as evaluation criteria. The aim of this paper is to investigate the validity of the assumptions, to assess the robustness of the results which are based on them, and to put forward some suggestions for improving the quality of the results.

Mesh:

Year:  1988        PMID: 3382497     DOI: 10.1016/0001-4575(88)90004-8

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  3 in total

1.  Effect of trail design and grooming on the incidence of injuries at alpine ski areas.

Authors:  K A Bergstrøm; A Ekeland
Journal:  Br J Sports Med       Date:  2004-06       Impact factor: 13.800

2.  Regression to the mean. A threat to exercise science?

Authors:  Roy J Shephard
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 3.  Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease.

Authors:  Sophie Lanzkron; John J Strouse; Renee Wilson; Mary Catherine Beach; Carlton Haywood; HaeSong Park; Catherine Witkop; Eric B Bass; Jodi B Segal
Journal:  Ann Intern Med       Date:  2008-05-05       Impact factor: 25.391

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.